Page 68 - IJB-10-6

International Journal of Bioprinting Semi-solid extrusion for pediatric medicine

19. Vieira I, Sousa JJ, Vitorino C. Paediatric medicines – 31. Kirkevold Ø, Engedal K. Concealment of drugs in food and
regulatory drivers, restraints, opportunities and challenges. beverages in nursing homes: cross sectional study. BMJ.
J Pharm Sci. 2021;110(4):1545-1556. 2005;330(7481):20.
doi: 10.1016/j.xphs.2020.12.036 doi: 10.1136/bmj.38268.579097.55
20. Huss G, Barak S, Reali L, et al. Drug Shortages in Pediatrics 32. Mercovich N, Kyle GJ, Naunton M. Safe to crush? A pilot
in Europe: the position of the European Pediatric Societies. study into solid dosage form modification in aged care.
J Pediatr. 2023;261:113472 Australas J Ageing. 2014;33(3):180-184.
doi: 10.1016/j.jpeds.2023.11347 doi: 10.1111/ajag.12037
21. Atif M, Sehar A, Malik I, Mushtaq I, Ahmad N, Babar ZUD. 33. Kelly J, Wright D. Administering medication to adult
What impact does medicines shortages have on patients? patients with dysphagia. Nurs Stand R Coll Nurs G B 1987.
A qualitative study exploring patients’ experience and 2009;23(29):62-68.
views of healthcare professionals. BMC Health Serv Res. doi: 10.7748/ns2009.03.23.29.62.c6928
2021;21(1):827. 34. Lemarchand C, Bienaymé H, Rieutord A, Abbou S,
doi: 10.1186/s12913-021-06812-7 Annereau M, Bastid J. Dispensing oral temozolomide in
22. ASHP Expert Panel on Drug Product Shortages, Fox children: precision and stability of a novel and ready to
ER, Birt A, et al. ASHP guidelines on managing drug use liquid formulation in comparison with capsule derived
product shortages in hospitals and health systems. mixtures. Pharmaceutics. 2023;15(12):2711.
Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst doi: 10.3390/pharmaceutics15122711
Pharm. 2009;66(15):1399-1406. 35. ANSM. Monographie Préparation magistrale Amoxicilline
doi: 10.2146/ajhp090026 125 mg, 250 mg et 500 mg, gélules réalisées à partir de MPUP
23. Butterfield L, Cash J, Pham K, Advocacy Committee for the d’Amoxicilline trihydratée; 2023. Accessed December 12,
Pediatric Pharmacy Advocacy Group. Drug shortages and 2023.
implications for pediatric patients. J Pediatr Pharmacol Ther https://ansm.sante.fr/uploads/2023/12/26/20231226-
JPPT Off J PPAG. 2015;20(2):149-152. amoxicilline-trihydratee-monographie.pdf
doi: 10.5863/1551-6776-20.2.149 36. EDS Form Group. Aprépitant : avis d’expert sur les
24. Metzger ML, Billett A, Link MP. The impact of drug shortages formulations extemporanées;2024. Accessed May 16, 2024.
on children with cancer--the example of mechlorethamine. https://www.edqm.eu/documents/52006/1912832/
N Engl J Med. 2012;367(26):2461-2463. A p r%C3%A9p i t a n t%20-%20A v i s%20
doi: 10.1056/NEJMp1212468 d%E2%80%99expert%20sur%20les%20formulations%20
extemporan%C3%A9es.pdf/02dc9885-c08b-e8f3-
25. Allen HC, Garbe MC, Lees J, et al. Off-label medication 4554-b46bec47014a?t=1713795079735
use in children, more common than we think: a systematic
review of the literature. J Okla State Med Assoc. 2018; 37. Otsokolhich M, Annereau M, Bauters T, et al. SIOPE and
111(8):776-783. ESOP recommendations for extemporaneous compounding
of oral liquid medicine formulations in paediatric oncology.
26. Balan S, Hassali MAA, Mak VSL. Two decades of off-label EJC Paediatr Oncol. 2024;3:100163.
prescribing in children: a literature review. World J Pediatr doi: 10.1016/j.ejcped.2024.100163
WJP. 2018;14(6):528-540.
doi: 10.1007/s12519-018-0186-y 38. Annereau M, Toussaint B, Dufaÿ Wojcicki A, Dufaÿ S,
Diaz Salmeron R, Boudy V. [2D-3D printing in hospital
27. Koszma EIA, Bispo AJB, Santana IA de O, dos Santos pharmacies, what roles and challenges?]. Ann Pharm Fr.
CNODB. Use of off-label medications in a neonatal intensive 2021;79(4):361-374.
care unit. Rev Paul Pediatr. 2021;39:e2020063. doi: 10.1016/j.pharma.2021.01.002
doi: 10.1590/1984-0462/2021/39/2020063
39. Tagami T, Ito E, Kida R, Hirose K, Noda T, Ozeki T. 3D
28. Meng M, Lv M, Wang L, et al. Off-label use of printing of gummy drug formulations composed of gelatin
drugs in pediatrics: a scoping review. Eur J Pediatr. and an HPMC-based hydrogel for pediatric use. Int J Pharm.
2022;181(9):3259-3269. 2021;594:120118.
doi: 10.1007/s00431-022-04515-7 doi: 10.1016/j.ijpharm.2020.120118
29. Meng M, Zhou Q, Lei W, et al. Recommendations on off- 40. Thabet Y, Klingmann V, Breitkreutz J. Drug formulations:
label drug use in pediatric guidelines. Front Pharmacol. standards and novel strategies for drug administration in
2022;13:892574. pediatrics. J Clin Pharmacol. 2018;58(S10):S26-S35.
doi: 10.3389/fphar.2022.892574 doi: 10.1002/jcph.1138
30. Richey RH, Craig JV, Shah UU, et al. MODRIC - Manipulation 41. Vijayavenkataraman S, Fuh JYH, Lu WF. 3D printing and 3d
of drugs in children. Int J Pharm. 2013;457(1):339-341. bioprinting in pediatrics. Bioengineering. 2017;4(3):63.
doi: 10.1016/j.ijpharm.2013.08.061 doi: 10.3390/bioengineering4030063

Volume 10 Issue 6 (2024) 60 doi: 10.36922/ijb.4063